By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teijin Pharma 

1-1, Uchisaiwaicho 2-chome, Chiyoda-ku

Tokyo    100-8585  Japan
Phone: 81-42-581-4321 Fax:



Company News
Teijin Pharma To Establish New R&D Center To Accelerate Integrated Pharmaceutical Development 10/6/2014 8:08:52 AM
Teijin Pharma To Develop Sheet-Type Fibrin Sealant For Surgical Operations 6/20/2014 8:50:01 AM
Teijin Pharma Launches WalkAide Device in Japan to Help Stroke Survivors and Others With Partial Paralysis Resume Walking 4/25/2013 10:53:40 AM
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan 1/17/2013 9:20:05 AM
Teijin Pharma's Febuxostat (FEBURIC) Launches in Taiwan - Novel Drug for Treatment of Hyperuricemia With Gout 5/10/2012 9:05:25 AM
Teijin Pharma and Menarini Group Conclude Distribution Agreement for febuxostat in Central and South America, CIS and Oceania 4/11/2012 8:43:32 AM
Teijin Pharma's Bonalon Bag for I.V. Infusion 900 µg Approved as Japan's First I.V. Drug for Osteoporosis 1/18/2012 9:04:41 AM
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma 1/12/2012 9:26:59 AM
Astellas Pharma Inc. Obtains China Rights to Teijin Pharma's Gout Treatment 4/2/2010 11:07:51 AM
Bristol-Myers Squibb Company (BMY) (JOBS) Enters Global Collaboration with Nissan Chemical Industries, Ltd. and Teijin Pharma on Novel Atrial Fibrillation Compound; Bristol to Pay $40 Million for Heart Drug 3/5/2009 7:46:47 AM